Netherlands Heart Journal

• Preface

29th Congress of the European Society of Cardiology

• Hot lines

Hot line 1

J. P. Ottervanger

• Hot lines

Hot line II

H. M. Nathoe

• Hot lines

Hot line III

A. J. Teske, J. S. S. G. de Jong

• Clinical trial updates

Clinical trial update I

P. G. Postema

• Clinical trial updates

Clinical trial update II

E. E. van der Wall

• Satellite symposia

Past, present and future of ACE inhibitors

S. G. Molhoek

• Satellite symposia

The bridge to achieving the greater LDL-C goal of <70 mg/dl: inhibiting cholesterol absorption and production

A. H. E. M. Maas

• Satellite symposia

The future of interventional therapy in cardiology

L. F. Tops

• Satellite symposia

Echocardiography: a new window for the heart

N. Marsan Ajmone

• Satellite symposia

If inhibition: the new strategy in cardiovascular risk management

I. R. Henkens

• Satellite symposia

Setting the standard in pulmonary hypertension management

S. G. Molhoek, H. W. Vliegen

• Satellite symposia

New evidence in the management of cardiovascular risk: the place of heart rate

D. A. Pijnappels

• Satellite symposia

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

M. V. Huisman

• Satellite symposia

Innovative device technologies for optimised heart failure management

J. A. Kragten

• Highlight session

Highlight session

C. Ypenburg